HPV DNA Associates With Breast Cancer Malignancy and It Is Transferred to Breast Cancer Stromal Cells by Extracellular Vesicles.
Human Papillomavirus (HPV)
circulating HPV DNA
extracellular vesicles (EVs)
stromal cells
triple negative BC
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2019
2019
Historique:
received:
05
04
2019
accepted:
20
08
2019
entrez:
15
10
2019
pubmed:
15
10
2019
medline:
15
10
2019
Statut:
epublish
Résumé
A causal link between Human Papillomavirus (HPV) and breast cancer (BC) remains controversial. In spite of this, the observation that HPV DNA is over-represented in the Triple Negative (TN) BC has been reported. Here we remark the high prevalence of HPV DNA (44.4%) in aggressive BC subtypes (TN and HER2+) in a population of 273 Italian women and we convey the presence of HPV DNA in the epithelial and stromal compartments by
Identifiants
pubmed: 31608222
doi: 10.3389/fonc.2019.00860
pmc: PMC6756191
doi:
Types de publication
Journal Article
Langues
eng
Pagination
860Subventions
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Informations de copyright
Copyright © 2019 De Carolis, Storci, Ceccarelli, Savini, Gallucci, Sansone, Santini, Seracchioli, Taffurelli, Fabbri, Romani, Compagnone, Giuliani, Garagnani, Bonafè and Cricca.
Références
J Biomed Sci. 2019 Jan 12;26(1):7
pubmed: 30634952
Nat Med. 2000 Jul;6(7):769-75
pubmed: 10888925
Front Oncol. 2016 Jan 08;5:298
pubmed: 26779441
Oncogene. 2017 Feb 16;36(7):877-884
pubmed: 27546617
Future Microbiol. 2018 Feb;13:187-194
pubmed: 28975808
Infect Agent Cancer. 2016 Mar 14;11:14
pubmed: 26981149
Viruses. 2017 Aug 07;9(8):
pubmed: 28783104
Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457
pubmed: 28223433
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9155-61
pubmed: 27432966
Front Oncol. 2019 Feb 21;9:93
pubmed: 30847303
Nat Commun. 2017 Mar 06;8:14470
pubmed: 28262727
Nucleic Acids Res. 2017 Jan 4;45(D1):D499-D506
pubmed: 28053164
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1165-71
pubmed: 24667602
Breast Cancer Res. 2005;7(1):R1-11
pubmed: 15642157
Cancer. 2015 Oct 1;121(19):3455-64
pubmed: 26094818
Clin Oncol (R Coll Radiol). 2019 Feb;31(2):81-90
pubmed: 30385006
Oncotarget. 2017 Jun 20;8(25):41717-41733
pubmed: 28402944
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
New Microbiol. 2015 Apr;38(2):211-23
pubmed: 25938746
Oncotarget. 2017 Mar 21;8(12):19592-19608
pubmed: 28121625
Oncotarget. 2017 Oct 9;8(56):96419-96432
pubmed: 29221217
PLoS One. 2012;7(5):e36766
pubmed: 22574222
Cancer Lett. 2018 Apr 28;420:182-189
pubmed: 29410005
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6328-33
pubmed: 20304794
Biol Cell. 2016 Jul;108(7):189-204
pubmed: 27018635
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):192-198
pubmed: 30599188
Cell Death Differ. 2009 May;16(5):749-57
pubmed: 19219067
J Pathol Clin Res. 2016 Jun 28;2(4):201-209
pubmed: 27917295
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Sci Rep. 2017 Sep 14;7(1):11561
pubmed: 28912498
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Neuro Oncol. 2014 Jan;16(2):298-302
pubmed: 24285549
Br J Dermatol. 2003 Jul;149(1):64-73
pubmed: 12890196
Bioinformatics. 2011 Mar 15;27(6):863-4
pubmed: 21278185
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
Oncoimmunology. 2013 Jan 1;2(1):e22565
pubmed: 23483742
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
PLoS One. 2014 Dec 05;9(12):e114559
pubmed: 25478862
BMC Cancer. 2012 Sep 24;12:421
pubmed: 22998595
Oncogene. 2013 May 30;32(22):2747-55
pubmed: 22797057
Int J Gynecol Cancer. 2012 Mar;22(3):343-7
pubmed: 22214962
Virol J. 2014 Nov 21;11:190
pubmed: 25413873
J Gynecol Oncol. 2019 Jul;30(4):e52
pubmed: 31074234
Semin Cell Dev Biol. 2017 Jul;67:11-22
pubmed: 28077296
Int J Cancer. 2015 Jul 1;137(1):12-24
pubmed: 25186851
Protein Pept Lett. 2016;23(7):656-63
pubmed: 27117741
Front Endocrinol (Lausanne). 2017 Aug 08;8:194
pubmed: 28848498